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A B S T R A C T
This survey highlights some of the fine structures and functions associated with estrogen in the human testes,
ageing and contraception. Clarifications obtained with knockout mice models as well as some clinical in-
vestigations showed that estrogen receptors significantly influenced the overall maintenance of the testis
functions through aromatase activity, intervening in the testosterone production by the Leydig cells and, in-
directly with the Sertoli cells. Other autocrine, paracrine and endocrine fading activities of the seminiferous
tubule's interstitium, including vascular supply, curtail the maturation of the male gametes while maintaining
the blood-testis barrier in ageing. Do Reinke, Charcot-Böttcher and Lubarsch crystalloids, biopsy markers of
specific testis cells, resulted of normal or altered functions and/or accumulated deposits out of ageing? The
hypothalamo-pituitary-testis axis and feed-back homeostasis (with pineal influence?) regulating the re-
productive tissues and phenotype characteristics, can be progressively changed according to individual health
history, encompassing life time accumulated environmental toxicants, pharmaceuticals, and age-reduced car-
diovascular fitness. The monitoring of all those long-term effects is needed to be better understood to provide
future human public health in the care for the old adult, aging population.
‘Causa latet, vis est notissima’ [The cause is hidden, the result is very
evident], Ovidius, Metamorphoses, IV. 287.
1. Introduction
Biomedical science's courses comprise studies on the reproductive
systems in which gonads in all animals, including humans, are included.
The male testes (or testicles) as in " two together”, considering the slang
uses in the Ancient Greek ‘παραστάται ‘(i.e. parastátai, “colleagues’),
are homologous to the female ovaries. There, the developed and mature
structures and functions classic views are that the developed and ma-
tured structure and functions of the testes are regulated by the episodic
hypothalamus gonadotrophin (GnRH) secretions whose stimuli act via
the hypothalamo-pituitary portal vessels to induce a pulsatile expres-
sion of both secretions of some of the basophil and eosinophil cells of
the anterior pituitary gland: the luteinizing hormone (LH) and/or the
follicle-stimulating hormone (FSH). Thus, on one hand, classic view
notes that LH influences the interstitial cells of Leydig's LH receptors
(LHR) to produce the gonadal testosterone (T) to influence spermio-
genesis of the spermatogenesis and making androgens, including di-
hydrotestosterone (DHT). Levels of T free serum and transported by a
circulation carrier, with that of DHT, also contribute in characterizing
the ‘male’ phenotype, by influencing other accessory male reproductive
organs and tissues. On the other hand, FSH has receptors on Sertoli cells
of the seminiferous tubules and upstream ducts exiting the testes
modulating spermatocytogenesis of the spermatogenesis i.e. taking the
haploid spermatogonia to spermatocytes and producing estrogens and
having receptors for it. These sex steroid secretions of the testes feed
back to that hypothalamo-pituitary axis and are also autocrine to their
tissues of origin [i.e. 1-3]. (see Table 1)
Caracteristically associated with the female gender or sex as ‘female’
sex steroid hormone, discovered to cycle the guinea pig, a century ago
[4,5], estrogen and estrogen receptors have also been detected in dif-
ferent cells of male's organs about 20 years later [6].
Ageing changes can modify the male organs and steroid influences
as hormonal activities linked with the typical testes functions thus,
estrogen changes would reveal a lesser considered aspect of the human
male reproductive system resulting in or accompanying other disorders,
including prostatic cancer. This apparently minor estrogen functions in
the male reproductive system along with some of these aforementioned
topics, have not and are not yet even alluded in textbooks of micro-
scopic anatomy and should get adjusted with pathology and physiology.
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After more than 40 years in biomedical publications, it is time to reveal
these basic hormonal, homeostatic activities, especially since general
practitioners have to be trained to likely later provide care to an in-
creased ageing population and stimulate further translational in-
vestigations [7]. Perhaps the neglected actions of the pineal, in view of
seasonal or cyclic influences mainly relegated or considered for rodents
[8] and those of prolactin, made by the acidophil cells of the pituitary
gland as suggested by some tumors [7,9–13] could render later on the
topic even more complex, but worth considering, in view of modern
living behaviors and the complex medical problems of the individual.
This can include portrayals brought by unprepared media when trans-
gender and gender changes are brought into public sensationalism.
In this brief review, we have also attempted to highlight the known
functions of estrogen in mature males and considerations about the
antagonistic effects of estrogen-like or xenosteroid disruptors favoring
some of the structural and dysfunctional atrophy bearing functional
similarities of the aged human conditions (decreased sperm counts,
cryptorchidism, hypospadias and testicular cancer) [14–17].
2. Materials
This survey has been created out of from literature searches
throughout public access systems, including the public accessed United
States Library of Medicine internet site (https://www.ncbi.nlm.nih.
gov/pubmed) as well as Google search access. Illustrations were ob-
tained out of old microscopic preparations available to medical and
biomedical students, at the University of Namur, Namur, Belgium,
made by and for the Laboratory of Cells and Tissues between 1965 and
1980 out of necropsies from human body donations. Those histology
sections were prepared out of at least one human adult (> 40 year old
male) and another sample from specimens from an elderly (> 80 years
of age), after body perfusion embalming, tissues were further fixed in
formalin and processed in paraffin sections, stained with either hema-




Named originally ‘oestrin’ and isolated as ‘an ovarian hormone’ by
Nobelists Allen and Doisy [18] and Butenandt [19]. The steroid is in-
volved in cyclical changes associated with procreation, or oestrus
[20,21], a topic reviewed in Medvei [22]. The American English ‘es-
trogen’ for the English ‘oestrogen’ is used throughout this survey. It is
derived from ancient Greek ‘οίστρος’ (or oistros, meaning ‘oestrus’ as
‘inspiration’ meaning figuratively ‘sexual passion or desire’) and a suffix
‘γένος’ (or genos as ‘producer of’) i.e. generating the periodic state of
sexual activity of females of most mammals [23]. The term ‘estrogen’ as
used in the previous paragraph and in the following text is meant ‘fe-
male sex steroids’ and as a ‘general’ term used to encompass, in male
tissues, the following three steroids and their metabolites: estrone (E1)
has one, estradiol (E2) has two, estriol (E3) has three hydroxyl groups.
However, 17β-estradiol (estradiol or E2) is the most prevalent in ac-
tivity of E1, E2 and E3 in human and mammals; another type of
estrogen, called estetrol (E4), produced during female pregnancy, was
evidently not included [23–25]. Thus, E2 abbreviation used is for all sex
steroid estrogens throughout the text, including those circulating in
lesser amount or/and active metabolites.
3.2. E2 functional aspects and gender differences
E2 is commonly known as a hormone secreted by the ovaries
throughout the reproductive span of reproductive activity in the female.
Ovary estrogen is responsible for various mechanisms ranging from
forming the female phenotype, promoting the cyclical growth of folli-
cles, and preparing for pregnancy several organs to reducing in-
flammatory effects in females [26], and even the level of pain percep-
tion [27]. The ovaries are the major source of circulating estrogens in
females as evidenced by oophorectomy, entirely removing estrogen;
this simple amputation has allowed a more clear and early under-
standing of estrogen functions in cases of endocrine dysfunctions. This
is in contrast when compared in males where a diffuse production of
estrogen meant that there are intricate estrogen-deficient productions
and thus, less understood. It has been documented that estrogen plays a
large role in spermatogenesis and in maintaining libido [28]. Estriol
[E2] is a most active form of estrogen steroid molecule that has been
found to be a clinically significant; however, compared with the female
gender, E2 level in men is still above that found in postmenopausal
women [29,30] and is able to carry out the endocrine and autocrine
effects noted in the human male reproductive system [9,30–37].
3.3. E2 production is through consumption of testosterone by CYP19A1
aromatase
Revisiting biochemistry basics, one recalls that cholesterol is the
precursor molecule modified by the desmolase CYP11A into pregne-
nolone, then by a mitochondrial dehydrogenase into progesterone. This
latter becomes testosterone (T) through CYP17 hydroxylase activity
[3,7,28–37], a member of the cytochrome P450 reductase enzyme su-
perfamily. Finally, another cytochrome P450 reductase enzyme
CYP19A1 (aromatase or EC 1.14.14) modifies T into E2 and related
steroid metabolites. This key enzyme is required for E2 production; it
not only plays a crucial role in testicular maintenance but it consumes T
produced by Leydig cells in the interstitium. T has been shown to de-
crease with age in both humans and rodents [3,8,9,15,30–39] and, thus,
the plasma level T and some of its metabolites, with inhibin, can in-
fluence back the same hormone's release by gonadotrophs to see an E2
increased in seminal plasma [39,40].
T actions throughout the male body has anabolic actions and on
specific reproductive organs can be episodically stimulated and mostly
converted as E2, as mentioned above. A small other source of E2 is
androstenedione, originating from the suprarenal zona reticularis.
Recent studies showed that human CYP19A1 gene is located in the 21.2
region of the long arm of the chromosome 15 (i.e. 15q21.2 region [41].
In addition to regulatory regions, this gene contains nine exons (exons
II–X) and contains 10 promoters, which are used according to the needs
and the characteristics of the tissue [42,43]. In comparison, mouse
CYP19 gene is localized on chromosome 9 where three promoters
specifically control the CYP19A1 gene expression [44]. Human ar-
omatase is mostly found in adipose tissues and only 10–25% in the
testes [6,31,45]. In final, the proper action of E2 as steroid depends on
two main factors: (i) the T converting enzyme and (ii) its receptors
found in various tissues and organs of the human male human including
the brain, the adipose and bone tissues, the skin (including the mam-
mary glands), the testes and the penis [3,30–37]. In comparisons, re-
ports suggest that high T concentrations inhibit spermatogonia pro-
liferation in models when spermatogenesis has been damaged by
processes such as irradiation [46]. During meiosis, T stimulates the
progression of spermatocytes through this process and inhibits apop-
tosis [47], and as seen later. E2 may there be co-operating with it. The
Table 1
Testis and main E2 Receptors in Human Seminiferous Tubule Cells.
Stroma Myoid cells LCs SCs Spgonia Spcytes Spids Spzoa
ER-As ER-Bs ER-As ER-Bs ER-Bs ER-As ER-Bs
Abbreviations: ER-As = E2 alpha receptors; ER-Bs = E2 beta receptors;
LCs = Leydig cells; Scs = Sertoli cells; Spgonia = Spermatogonia;
Spcytes = Spermatocytes; Spids = Spermatids; Spzoa = Spermatozoa; Stroma:
mainly myoid cells.
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site of action of androgens in spermatogenesis has been extensively
studied [48–51].
The diffuse E2 production in males means that there are potential
complex endocrine dysfunctions in male's E2-deficient productions
compared with females. This diversity of actions due to receptors and
multiplicity of target tissues has probably hindered progress in the
understanding of clinical deficient cases and patterns of the male
human tissues [6,9,38,40]. Even though numerous biomedical studies
have used successfully murine models to clarify the many sites of ar-
omatase activities, one may still be careful in validating those data for
humans which may still have differences in functionality or regulations
[30–40,45–52]. Aromatase, the main enzyme converting androgens to
E2, is also found in Leydig cells, Sertoli cells, germ cells and elongated
spermatids in the male reproductive system [37,38]. Therefore, if any
of these locations housing aromatase were to decrease or disappear, a
reduction in E2 production would result. Factors known to increase
aromatase activity include age, obesity, insulin, gonadotropins, and
alcohol. Aromatase activity is antagonized or decreased by prolactin,
anti-Müllerian hormone and the common herbicide glyphosate [15,17]
and explained in further paragraphs] and, in elderly, could it be that T
is tapped by 5-α reductase (EC 1.3.99.5) into more dihydrotestosterone
(DHT) and eventually favor benign prostatic hyperplasia (BPH) and
prostate cancer? [39] (Fig. 1).
In female, aromatase activity appears to be enhanced in certain E2-
dependent local tissue next to breast tissue, endometrial cancer, en-
dometriosis, and uterine fibroids. At this point, one could likely gen-
eralize that E2 (and some of its metabolites) or synthetic E2 (i.e. die-
thylstilbestrol or DES) are known to entice body receptive cells to enter
the cell cycle by stimulating DNA replication and typical or altered
transcripts, especially in cases of excessive unbalanced circulating le-
vels, estrogen would favor carcinogenesis [53–61]. E2 was found in
human testes Sertoli cells adenocarcinomas [48,51]. During differ-
entiation, germ cells are able to synthesize E2, acting as intracrine or
autocrine modulating factors of their own maturation [48–51]. E2 and
environmental non-estrogens but with E2-like activities have been
shown to be able to stimulate mammalian sperm capacitation, acro-
some reaction and fertilizing ability [60]. Many of these E2 effects were
mediated by cognate receptors, ligand-activated transcription factors,
binding to responsive components of the hormone-responsive genes
[37,38,45,53,54,60–65].
3.4. Aromatase excess syndrome and stress
A rare syndrome where in boys due to mutations in the CYP19A1
gene can induce gynecomastia and precocious puberty accompanied by
a rapid epiphyseal closure that leads to short stature. This condition is
inherited as an autosomal dominant fashion but the long-term anti-ar-
omatase treatment into adulthood and further is unknown [66,67].
Excess aromatase activity can be caused by medical procedures invol-
ving serious cardiovascular risks surgeries [68,69].
3.5. Aromatase deficiency syndrome
This syndrome is found in youth, caused by a mutation of gene
CYP19 and inherited in an autosomal recessive way. Accumulations of
androgens during pregnancy may lead to intact males but tallness due
to retarded epiphyseal closure. The aging outcome of this defect is
unclear at this time [70–72] while some effect could be preventative of
osteoporosis and can be worth further exciting clinical investigations
[73].
3.6. Inhibition of aromatase and environmental toxicology
This inhibition can result in hypoestrogenism and can be caused by
pharmacy and natural products, still quasi exclusively studied in
women [74–77]. These compounds are aimed to inhibit the production
of E2 in postmenopausal women; thus, a current clinical usage of
anastrozole, exemestane, and letrozole as they became useful in the
management of patients with breast cancer lesions found to be E2 re-
ceptor positive. Aromatase inhibitors are also beginning to be pre-
scribed to men on T replacement therapy as a way to keep E2 levels
from spiking once doses of T are introduced to their systems. Natural
aromatase inhibitors tend to cause fewer serious side effects than ta-
moxifen and related medications in elderly patients which can cause or
favor the heart, venous thromboembolic events (VTE), stroke and fre-
quent osteoporosis in some cases, and has yet to be evaluated more in
male patients [e.g. Ref. [69,73]. Other common disruptors of aromatase
are widely used in agriculture as herbicide and antifungal and their
long term toxicity measured in vitro and evaluated in cohorts of pa-
tients could harbor a large number of defects that are still to grow in
diagnostic among many farming populations, ignored by industrial
agriculture developments, unawareness or neglect of administrative
policies in public health [e.g. Ref. [74–88]. Finally, among traffic pol-
lutants, lead can affect fertility and therefore it is crucial that long-term
clinical surveys would verify this environmental public topic [78].
4. E2 production and the testes
The finding of the E2 source in human testes was originally derived
from dog experimentations [89] when rare Sertoli cell's tumors were
observed (e.g. Ref. [90,91]) or in some forms of seminiferous tubule
anomalies [92], varicocele [93] and cryptorchidism [37,94,95]. These
histopathologic structures induced by exogenous E2 were even more
pronounced when fetal or neonatal animals were exposed devel-
opmentally to high E2 levels though of synthetic diethylstilbestrol
(DES) or other natural or man-made environmental estrogens [93].
Those stimuli can produce permanent changes in the structure and
function of postnatal human male reproductive organs, similarly as
those found in females using rodent model offspring through more than
one generation [49,54–62,93]. Most of the DES animal studies have
been especially important because they have predicted some of the
extensive male abnormalities after DES exposure during pregnancy
[62,94,95] caused by the intratesticular sites of aromatization in the
developing tissues of human testes [36–38]. Measurement of E2 in
peripheral blood and urine [49,52] indicated that E2 is ‘very low in
humans’ and that ‘estrogen levels were also found in testis and in
semen’ [96]. The primary source in immature testes was first hy-
pothesized to be Sertoli cells, confirmed by the Sertoli cell tumors, and
later with in vitro studies [90,91,97]. Then, direct evidence that normal
Sertoli cells can synthesize E2 under the regulation of FSH and cyclic
AMP. However, in adult and aging testes, studies have always con-
sented that the main E2 source was Leydig cells
[6,8,12,21,29,32–40,98–100] as proposed by Western and Northern
analyses [41,60–62,68,69]. Meanwhile, aromatase was also localized
by immunohistochemistry [74] in spermatogonia, elongating sperma-
tids and other associated tissues and organs of the male reproductive
system [9,32–40,60,61,70–73,100–103].
Fig. 1. The role of estrogen in the ageing process of the male reproductive
system appears to be triggered by the lack of blood flow to testicular cells.
While estrogen does not appear to play a role in initiating testicular atrophy, it
demonstrates the effect of promoting degeneration that is already in progress.
A. Hussain and J. Gilloteaux Translational Research in Anatomy 20 (2020) 100073
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4.1. E2 receptors
E2 hormone receptors (ERs) are located intracellularly in a similar
distribution as aromatase. In the testes seminiferous tubules, these re-
ceptors are localized in the cytoplasm and Golgi of the round sperma-
tids [32–37] while at least two types of ERs have been identified in
females, ER-alpha or α (ER-A) and ER-beta or β (ER-B); the same ones
have been found in males [104–107]. The most abundant ER found in
males is the ER-B form which is ubiquitous to almost every cell in the
interstitium and seminiferous tubules, but the ER-A, located specifically
in that interstitium have been found to play a key role in maintaining a
differentiated epithelium morphology and to regulate fluid reabsorp-
tion in the male reproductive system [32–37,104–109]. ER-A Knock
Out (ERA KO) studies conducted in mice have found the tall, ciliated
columnar shaped epithelial cells of the efferent ductules with abundant
microvilli to undergo metaplasia towards smaller, cuboidal shaped cells
with sparse microvilli.
E2 receptor makes possible to influence the differentiation of the
efferent ductular epithelium [105]. As KO studies indicated, compro-
mising ERs lead to atrophy and other morphological changes of the cells
they reside, thus, a lack and/or any compromised ERs could therefore
potentially be linked with testicular atrophy, also correlated with the
natural ageing process. E2, as any steroid hormone, diffuses through
plasmalemma, acts through nuclear receptors to ultimately regulate
gene transcription and expression in a similar distribution as the
aforementioned aromatase in the testes [e.g. 32–37, 108–109]. Animal
models, such as rabbit, rats and mice (wild and KO) studies with the use
of radiolabeled E2, initiated by Mulder and the group of van Beurden-
Lamers [105,106,108] have been able to make the human physiology
understood about the E2 role in the male reproductive system, along
with the understanding of E2 receptor biology. Out of a study con-
ducted in 1996, knocking out (KO) estrogen receptors in male mice, in
particular the ER-A, exhibited a pattern of progressive testicular tissue
degeneration [111]. This further supported by more recent studies in-
dicating that the ER-A is implied to mediate testicular germ cell dif-
ferentiation through a mechanism involving Sertoli cells [112,113]. It
should be noted that rats ER-A KO showed no significant impairment in
spermatogenesis; this is in stark contrast with aromatase KO studies
[111]. These findings exemplify the higher function E2 synthesis and
presence plays in spermatogenesis and overall testicular health. The
ERs are required for the effects of E2 to be observed thus, a destruction
of these receptors can come along with the effects of testicular changes
through ageing, thus can help further progress toward their involution
process. Other studies investigated the opposite end of the spectrum by
artificially increasing the production of ERs in mice which lead to
Leydig cell hyperplasia, cryptorchidism and undescended testis all re-
sulting in lower testosterone levels [30,63]. These other data could
potentially be due to a shunt-like effect where an increased number of
receptors for E2 calls for an increased production of E2 thus depleting
testosterone levels halting the dissention of the testis, one of the effects
of normal testosterone function. With increased amount of E2 receptors
linked with Leydig cell hyperplasia, it can logically be extended that a
lack of E2 can potentially result in hypoplasia, decreased function and
eventual testicular atrophy in the human male reproductive system.
Reports on human testis tissues [38,40,100–108,113–122] showed
most cells with both ER-A and ER-B receptors but with Leydig cells and
spermatogonia with quasi only ER-B. Another large series of other re-
ports are quoted in Ref. [37,38] while another review is mainly dealing
with the huge number of murine experiments [100–103]. One should
note that these conclusions only hold true if mice are assumed to be
adequate models for human males. These animal model studies hold a
strong argument for parallel investigation towards human ageing and
could potentially further aid in the search for a method to slow or ex-
tinguish the natural ageing process of the male reproductive system
where a proper balance between T and E2, through aromatase activity,
is key for an appropriate functioning during reproductive activity. In
the meantime, a large number of studies have verified those receptor's
action in primates, normal human and in pathology [65–72,113–138]
as well as medication against male osteoporosis [73].
5. Tunica vaginalis
The tunica vaginalis, serous membrane lining the human testis,
developed from the peritoneum [139,140] and, thus, pediatric testes
are considered intraperitoneal because the tunica vaginalis, a perito-
neum derivative, covers the testes. Studies have shown that, with
ageing, this usually liquid lining can adhere to the testis wall and ob-
literates the mesentery present on the testis. Thus, with ageing, the
testes appear behind the tunica vaginalis rather than inside [140]. This
loss of lining has been observed in other conditions such as cryp-
torchidism which has been associated with testicular atrophy [123]. If
this lining has been shown to be diminished in the elderly and a pa-
thological loss of it has been linked to testicular atrophy; therefore, it
should be reasonable to accept that the tunica vaginalis plays some key
anatomical role in maintaining testicular health.
6. Testis interstitial cells of Leydig or interstitial endocrinocytes
6.1. Ageing and hypogonadism?
The interstitial cells of Leydig (LCs), officially-named ‘interstitial
endocrinocytes’ [141], can be detected in the testis stroma, and usually
found adjacent to the seminiferous tubules [142–163]. A population of
‘fetal'-type mesenchymal cells are destined to become LCs from the 8th
to the 20th week of gestation, and produce enough testosterone until
birth and at puberty. ‘adult'-type LCs differentiate in the post-natal
testis. Indeed, they are preceded in the testis by masculinization of a
male fetus [7–10,14,34–37,99,156,157]. Leydig cells respond to LH
from some of the basophils of the anterior pituitary gland to produce T
in males with a decreased quality and production according to aging in
rodents [158,159] and humans [157,160], thus sustaining the gender
phenotype. LCs markers should express T through aromatase (see above
paragraphs) and Reinke crystal location [161,162], but also can be
identified through histochemical markers such as calretinin [162–166],
more specifically than with inhibin [167,168].
Mature LCs are polyhedral in shape, and have a large prominent
ovoid nucleus containing a prominent nucleolus, an eosinophilic cyto-
plasm with mitochondria, endoplasmic cisterns and numerous lipid-
filled vesicles, lipofuscin pigment and peculiar, rod-shaped crystal-like
structures (3–20 μm in diam.), as named ‘crystalloids of Reinke’ of no
known function [142–151], besides to be eventual marker of LC tumors
[160, 161, see paragraph 5.5 ] and Fig. 2 A-B versus Fig. 3 A-B.
LCs undergo obvious cell changes as the person ages
[99–104,156,157,168] and the same studies showed with a murine
Fig. 2. A-B Light microscopy preparation out of paraffin sections from a mature
human testis where the seminiferous tubules sections are busy by lining sper-
matogonia and other progeny gonocytes and spermatids. In the stroma, many
small circulatory vessels are surrounded by large eosinophil aggregates of
Leydig cells (arrows). B: enlarged aspects of Leydig cells containing Reinke
crystalloids as elongated rod-like shapes (arrows). Scale in A is 20 μm; in B it is
5 μm.
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model of accelerated Leydig cell ageing by knocking out the Nrf2 gene
responsible for protection against oxidative stress which led to loss of
cytoplasm and eventual atrophy of the cells as in primary hypogo-
nadism [168]. Such deficiency and in excess have been reported by
some of the early studies with histology in mammals, among others, the
equine type and human [142–151], (see Fig. 2A and B), including
electron microscopy [146–152,154,155], All LCs can produce T in the
presence of LH, as first demonstrated in mouse [37,111,152] which
level decreases with age as noted in rats [158,159], like those found in
human [30–37,147–162]. Age-related defects include altered transport
of cholesterol, a hormone precursor, into the mitochondria and LH-
stimulated cAMP production for intracellular signaling
[121,124,129,132,134,162]. In light of this evidence, it stands to
reason that ageing can reduce testosterone function by mechanisms
reducing the T production of the LCs as in hypogonadism [163–165].
Studies reveal that the age-like effects observed in the testes are not due
to a decrease in LC count, but rather by a sort of cooperation in the
ability of the cells to make T in response to LH that could be resulted by
the ‘fitness’ of the associated, local vascular supply caused by blockade
or lag in gonadotropin response [148,168] The ER-A type receptors
(ERs-A), are located specifically in the interstitium of the testis, have
been found to play a key role in maintaining a differentiated epithelium
morphology and to regulate fluid reabsorption in the male reproductive
system [32–38]. Once T becomes scarce, its progeny, E2, will decrease
resulting in less protective factors and eventual further testicular
atrophy. It has been found that deletions or mutations causing impaired
aromatase enzyme formation in males has been linked with diminished
or even ablated steroidogenesis [30,34–37]. Additionally, a diminished
or lack of aromatase not only impairs steroidogenesis, but can also lead
to infertility and impaired spermatogenesis [7–10,14,34–37,151,157].
Since spermatogenesis requires proper LC and SC functioning, the
lowering E2, stemming from a significant altered aromatase, could be
the root of further testicular impairments [159–168]. This preservative
role is clearly highlighted in the female reproductive system.
It has been found that the total number of LCs in elderly male, over
the age of 60, can decrease to up to 44% [151,157,163,168,170].
Cellular changes include dedifferentiation, decreased amount of smooth
endoplasmic reticulum and mitochondria organelles, multinucleation,
and a greater number and larger sized Reinke crystalloid inclusions
[140–167]. The high oxygen demand established by the abundant mi-
tochondria in LCs places them at increased ischemic risk; these orga-
nelles demonstrating variable morphology according to metabolic ac-
tivity [170–172] and, along with them, the peroxisomes enzymes can
be implicated without increasing their catalase marker [173]. These
changes in LCs that come about through the natural ageing process in
the male reproductive system can compromise the functionality of the
cell thus contributing to a decline in estrogen production [163–170].
Other previous investigations showed with morphology, including
immunocytochemistry, the presence of clear and dense-core vesicles
and the co-location of several neuropeptides in LCs, making LCs a new
member of the diffuse neuroendocrine system [174]. However, studies
are yet to come with age changes in this topic.
In the testes, the LCs can be ectopically located, i.e. in the tunica
albuginea, the rete testis or the interlobular septa as well as within
hyalinized seminiferous tubules or those with advanced atrophy and
marked thickening of the tunica propria, i.e. tubules in adult cryp-
torchid testes, Klinefelter syndrome, and in some other primary hypo-
gonadisms as reported in a most recent contribution [175].
6.2. Leydig cells and aging alcoholism
In older men and in those with chronic alcoholism, LCs, as well as
ectopic LCs may show atrophic features [175].
6.3. Leydig cells and Werner's syndrome
Patients suffering from Werner's Syndrome, a known form human
progeria, are found to be lacking the gene for the production of WRN, a
protein necessary for preventing early onset senescence of tissue. WRN
appears to be only induced by E2 and not T; this also makes E2 a
protective agent against early senescence of the reproductive system
[20]. These findings suggest that a decreased and lack of estrogen can
cause progressive, diminished function of the male reproductive system
[176].
6.4. Leydig cell tumors
LCs tumors are usually benign [177] even though they involved
gonadotrophin perturbations or are irresponsive to gonadotrophin
[177–179], often associated with infertility. Estrogen production rates
and excretion were 5- to 10-fold elevated in 2 patients studied, but
could be entirely accounted for by tumor metabolism of circulating
steroids, notably dehydroepiandrosterone sulfate, and, thus E2 and
xenoestrogen exposure could participate in LC tumorigenesis
[163,177–179].
6.5. Crystalloids of Reinke
In 1896, Reinke [179] reported the rod or corn-shaped CRs struc-
tures measuring up to 20 μm in the LCs of the human testis. Named after
Reinke by others [143–146], he found them as rice-shaped with iron
hematoxylin staining preparations. It was then hypothesized accretion
to form larger ones, as suggested through electron microscopy ob-
servations [1,146–150,154–170,171-189]. In azoospermia, there are
cases when no crystalloid can be seen but pigments [190–199] and
there are said ‘to be inconsistent among individuals and among the cells
of an individual’ [148]. The crystalloids are variable in form and size
and are rectilinear. (about 3 μm in width et 20 μm long], with angles
that can be sharp or rounded as they are made of macromolecules 5 nm
in diameter and evenly spaced of 19 nm, present in highly ordered
pattern of internal structure. For other authors [192–194] and, as re-
ported in Ref. [195], the hexagonal lattice has a 24 nm constant. These
peculiar inclusions likely relate to LC steroidogenesis because a similar
type of crystalloids was detected in the adrenal cortex [192], the ovary
LCs [196] and even in human SCs [196] and swine, including the
cryptorchid ones [198]. In cases of azoospermia the same LCs contained
fatty deposits with initially formed electron-pale deposits that appear
like those of cholesterol, as they are electron-lucent [199], thus re-
sembled cholesterol unesterified in the human gallbladder and cystic
duct cholesterolosis [200,201]. Others, such as in Ref. [202] have
classified these LC deposits. Authors have also found ectopic LCs and
Reinke crystals relationships, are these deposits formed through normal
functions or metabolic defects or/and ageing deposition of proteinac-
eous residues? [203–205]. When observed with the light microscope,
Fig. 3. A-B Light microscopy preparation out of paraffin sections from an el-
derly human testis where the seminiferous tubule sections display a poor lining
and luminal content, a thickened basal membrane, when compared to mature
testis (Fig. 2A). The stroma appears poorly populated due to a poor stromal cell
population, including Leydig cells. They are rare and scattered (arrows) among
the stromal spaces with vacuolated content (lipids) and only small Reinke
crystals (arrow). Scale in A is 20 μm and in B is 5 μm.
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old human testis samples do not obviously display the crystalloids in
the LCs as in mature testes (Fig. 2 A-B and 3 A-B).
7. The seminiferous tubules
7.1. The Sertoli cells and the blood-testis barrier
These male reproductive, tubular organs have been described long
ago, and Sertoli [206,207] (and its recent translated version about ro-
dents [207]), demonstrated how the reproductive maturation of male
gonocytes matured in the testis along with large cells, named after
Sertoli.
Briefly, these blind-end, highly convoluted tubular ducts of the
testes are contained in the interstitium where LC's aggregates located,
bordered by a basement membrane lined by one to more myoid cells
(smooth muscle-like cells), a loose connective tissue abundantly vas-
cularized, including lymph capillaries [148–152,206–210]. The semi-
niferous ducts are lined by prominent, somewhat columnar to pyr-
amidal, branching-shaped cells, named Sertoli cells (SCs), bearing an
oblong nucleus and large nucleolus body, annulate lamellae, some lipid
and pigments deposits along with markers, the Charcot-Böttcher crys-
talloid deposits. SCs support of the stem cells and proliferating gono-
cytes and have phagocytic capabilities of capture of spermatid cyto-
plasmic excessive cytoplasmic pieces before spermiation. SCs were
described, reconstructed in 3-D aspects by Sertoli [206] and have been
surveyed throughout the vertebrates, including humans
[148–152,209–218]. SCs bear multiple alcove-like depressions, viewed
in 3-D profiles, where nest the ascending, maturing gonocytes in the
adluminal compartment. The gonocytes and progeny, up to spermatids,
are attached along SCs via desmosome-like junctions, gap junctions,
ectoplasmic specializations and tubulo-bulbar complexes [148–152].
SCs are attached to the basal lamina they make via hemidesmosomes,
and to each other by desmosomes, gap junctions, and tight junctions
(the essential junction to constitute what is named the ‘blood-testis
barrier’ (or BTB). Altogether, without the gonocytes, SCs constitute the
lining of the rete testis ducts joining the efferent ducts outside the testis
through the mediastinum testis. This BTB have also an important bar-
rier preventing any autoimmune defects [215–218]. During the normal
process of spermatogenesis, the gonocytes as spermatogonia B cross the
BTB and reach the adluminal compartment [Stanton, 148–151]. This
BTB constitutes a sort of ‘dynamic fence’ corralling a basal compart-
ment that contains the stem cells, i.e. spermatogonia type Ad (A dark)
and type Ap (or A pale) which mitotic activity of the latter one (2n).
There, associated with SC's recesses and diffusing factors, SC influence
further their maturation during meiosis and further progresses of
spermatocytogenesis. The interconnected SC epithelial cells cliched
along its topologically-located spiral cargo bays organized to move
upwardly the spermatocytes and spermatids until spermiation, via
transient changes of the SC cytoskeleton [216–226]. There, the mi-
crotubules cytoskeleton seemingly supportive of other adhesive cytos-
keletal regulatory proteins (especially claudin 11 [223–228]) are ne-
cessary to maintain normal spermatogenesis through the integrity of
the BTB, which expression of normal, functional constitutive cytoske-
leton and gap junctions (connexin 43 [229]) depend on hormonal in-
fluences, including that of E2 associated with other factors [229–237].
However, as noted by investigators, ‘the regulatory mechanisms and
changes in junctional proteins that allow this translocation step without
causing a ‘leak’ remain poorly understood’ [233] even though some
recent clarifications have been carried out [228–235].
During puberty, SCs cease to divide and their population appears
stable throughout the lifespan of animals and human
[149–151,203,208,209], However, with further ageing, SCs decreased
size make them less easily recognizable in microscopic anatomy, as
young medical students realized, if they had access to aged tissue's
histology preparations (Fig. 2 A-B and 3 A-B). Their reduction in size, at
first, among the tubules, and number, similarly to LCs, under hormonal
stimuli maintenance, reduced their population with old age
[149,215,231], this progressive cell lessening also contributes to the
decreasing spermatogenesis through reduced proliferative index of
sperm cells have been measured and, thus, ultimately to testis atrophy
[148,151,170,192,208,209,215]. Through ageing, the histological and
cytologic ultrastructure demonstrated degenerative patterns of orga-
nelles architecture, as well as the BTB. SCs can display vacuolization,
mitochondria metaplasia, dedifferentiation and even multinucleation
[148,150]. SCs maintain the blood-testis barrier (BTB), have a BTB,
with its components, the intermediate filament network or tensile
structures functions to protect spermatogonia differentiation until the
spermiation named for the ‘liberation’ of the spermatid-spermatozoa
gametes leaving the tubule's SCs for the rete testis, and further their
maturation in the epididymis [222–224,230].
7.2. Intricate hormonal interactions on Sertoli cells, including E2
SCs are not terminally differentiated [218] and express high levels
of pro-survival B-cell lymphoma-2 (BCL2) proteins, thus inhibition of
apoptosis and autophagic processing and prolongs SC survival upon
exposure to stress stimuli [237,238]. SCs respond to a complex ballet
performance directed by some hypothalamo-pituitary pulsatile stimuli
that interact, especially from acidophil cells [169,239], and, via bio-
logical circadian and seasonal cycles in rodents and, perhaps in hu-
mans. There, E2 and T, metabolites and alike (iodinated hormones)
altogether or in complex interactions modulate the expressing genes via
Krüppel-like factors [239–246] for some of the SC's paracrine main-
tenance of intercellular tight junction's components, or at least they can
become potential mediators of junctional assembly and disassembly
during the translocation process of the gonocytes by SCs towards the
lumen side spermatogenesis and spermatocytogenesis
[110,111,114,115,117,125,126,168,169,211–217, 237, 238], in-
cluding spermiation (see paragraph 5.3.).
Out of the hypothalamus, the gonadotroph FSH release in vivo or in
vitro favors aromatase activity and make SCs [247–249] to produce
some E2, metabolite derived from T, as found in human [250–252].
FSH acts on SC's maintenance [22,111,112,169] and ERs control pro-
teomics, including aromatase. There. Even if FSH has abnormal level, it
does not alter significatively SC morphology [215, 231, 249]. However,
prolactin (PRL) in excess can changes the tubule histology, favoring
degradation of SCs and the depletion of the seminiferous tubules of
germ cells [10,11,253]. For the other cells of the tubules, and maturing
gonocytes, it is beta types that have been found in males
[30,37,131,211] ubiquitous to almost every cell in the seminiferous
tubules. Early data finding E2 in human [251,252], then further studied
in KO mice [254] demonstrated that the tall ciliated columnar epithelial
cells of the efferent ducts, normally bearing long microvilli undergo
metaplasia changes towards smaller, cuboidal shaped cells, with sparse
microvilli, thus some atrophic changes without the E2 maintenance of a
differentiated status of these duct's epithelium [109,110]. Conse-
quently, E2 (and other cooperative hormones, i.e. androgen binding
protein or ABP- see later in 5.2. paragraph) is potentially linked to
testicular atrophy correlated with the ‘natural’ ageing process asso-
ciated with the E2 body depletion.
Despite E2 and ER-A and -B presence in males, and known deleterious
effects of perinatal E2 or DES treatment, there are now arrays of evidences
(SCs, spermiation) that E2/ER-A and-B signaling are important in the
spermatogenesis and spermiogenesis studied in rodents and, again, prob-
ably, in some aspects, in normal human reproduction. Possibly, other
longitudinal human studies would provide more information, especially
regarding the usage of environmental endocrine perturbators. It is also in
this topic that rodent's models, including KO murine, would be important to
clarify some aspects noted with poor understanding in human defects
[10,11,23,32–34,117,159,238,240,254] then observed in biopsies obtained
without creating autoimmune orchitis [255]. Studied throughout verte-
brates [203,205,213,214], mostly rodents, including KOmice [e.g. 247, and
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6,9, 28, 29, 30–36, 100, 101, 111, 195], made investigators grasp some
peculiar and unfamiliar functions of E2 in human
[29,38,39,52,102,114–116,215,216,248] and vice versa. These made find
in human bear two forms of ER commonly known as α (ERα, NR3A1) and β
(ERβ, NR3A2) have been cloned from human [117–122, 124, 248, 249].
There, SCs have high levels of ER-A.
BTB maintenance is crucial to testicle's integrity and functions,
especially for SC's cytoskeleton, apparently modulated by E2 [247–250]
and a series of hormones and factors, that included the secreting pi-
tuitary basophils (i.e. gonadotrope FSH [251] and thyrotrope ([e.g.
triodothyronine [252] as well as acidophils [growth hormone IGF-1
[253]) and the antagonistic prolactin (PRL [10,11,254]; The develop-
mental anti-Mullerian hormone [255,256], Other testicular factors for
differentiation, metabolism (retinoic acid and related factors
[258–260]), transport and proteases controlling phagosomes of sper-
matid maturation and digestion, can modulate SCs via feedback to the
pituitary (e,g, transforming growth factor β (TGFβ, activin A)
[257,258], inhibin alpha type [261–263], and even the C-type na-
triuretic peptide [264]. Simultaneously, in adult and aging, the an-
drogen binding protein (ABP), secreted in the seminiferous tubule
lumen with other compounds (i.e. transferrin [265]), maintained the
integrity of the inner structures of the tubules [265–269] that could be
investigated through selected biopsies [270].
One reiterates that the unclear significant (or awkward?) activity of
E2 in human seminiferous tubules have been constrained scientific
discussions, yet of biomedical or pathology interests, due to dwindling
funding at first, about the DES lesser impact on the afflicted population,
and also about animal research used as model for a human potent in-
terest and public health. It is true that the number of male patients
involved with DES related pathologies have diminished during the last
25 years, due to infertility [270]. However, xenoestrogens or similar
endocrine perturbators currently present in the environment and nu-
trients apparently as ‘safe’ additives may generate insinuating diseases,
not only in the developing reproductive organs, but could affect public
health, thus their investigations should create new regulations and
dietetic policies.
7.3. Spermiation
This process features an intracellular dynamic, cytoskeletal turnover
allowing millions of mature spermatids in late stage VIII in rodents
versus late stage II in human [271,272] and ‘released from SC into the
seminiferous lumen’ [272–274]. This turnover and reconstructed cy-
toskeleton is modulated by E2, metabolites and other factors surveyed
in the previous paragraph 5.2.
Again, many of these regulations verified in lower vertebrates and
mammals, including human but those have not been considered in
ageing [266,267] because evidences show that age significantly de-
creased the volume of the seminiferous tubules and, for some authors,
leaves the interstitium unchanged. However, in most cases, the ageing
process, like in Kleinefelter syndrome or infertile testes histopathology
[192,275-277], some breakdown of the blood-testis barrier induces
striking changes in the appearance of Sertoli cells and in their renewal,
further enhanced through any other degeneration, including of im-
mune-degenerative induced lesions. This includes the installation of a
progressive, histological sclerosis of the tubule tunica propria caused by
collagenization (change or modification of population of the lamina
propria, diverse lesions in the tubules, including a reduced spermio-
genesis (loss of diverse lining cells) [147–152] (Fig. 2 A-B vs Fig. 3A
and B).
7.4. 4. Crystalloid of Charcot- Böttcher
These fine structures were named after Charcot and Böttcher [278]
seen in SCs .Sorts of histologic curiosity, their nature is still unclear
even though they seemed to have become markers of the Sertoli cells in
biopsies in young adults, adult fertile or not, and tumor cells even
though out of some electron micrographs, their features appeared more
like amassed filamentous -intermediate filament-like amassed. The
‘crystals’ are constituted as 10–25 μm in length, spindle-shaped; they
stain with eosin with hematoxylin-eosin, Mallory's aniline blue, phos-
photungstic acid, tetrazolium compounds and Coomassie brilliant blue.
Furthermore, they seem proteinaceous packets viewed with the electron
microscope as fascicles made of parallel fibrillar arrays with variable
spaces; the fibrils ranged from 9 to 11 nm in width. They appeared in
continuity with the intermediate filaments of the perikaryon
[278–292]. Some authors described them connected with the nuclear
envelope as well as with the rough endoplasmic reticulum. They ac-
company accumulation of lipid droplets, sometimes poorly developed
as ‘paracrystalline’ [150,152,278–291], also found in marsupials and
tree-toes sloths [292]. Are these related to ‘aging’ germ cells or dis-
function of the maturing cells?
7.5. The spermatozoa
The progeny of mitotic spermatogonia differentiates into meiotic
spermatocytes, that elongate as spermatids (1n, haploid) under the
nursing ‘supervision’ of SCs [293,298–300] and E2 activity
[46–51,125,126,212,213,300,301]. It is without forgetting that ga-
metes since their beginning as spermatogonia are quasi syncytial as
they connect with cytoplasmic bridges until spermiation, excising each
perikaryon and excessive cytoplasm, making them male motile gametes
[147–152,170,294–297,299,300]. ERs type beta (ER-B) receptors (2
types) found in human [125,126,299,301–305]. E2 stimulus appears to
favor survival according to in vitro report [306]. Verified in rodents
[45–48,307–309] ERs were predominantly located in the pachytene
spermatocytes and associated with the midpiece endoplasmic reticulum
and their rich mitochondria content location [306]. with the Golgi
apparatus of the round spermatids, the spermatid and spermatozoa
strictly demonstrated aromatase in the midpiece region, where the
main endoplasmic reticulum is localized [e.g. 36, 37, 109–110,
302–303]. Similarly, in rodents, B type spermatogonia are strongly ER-
B immune-positive, whereas the highest levels of ex-pression of ER-A
are observed in round spermatids [48–51]. In the final stage of sper-
miation and motility, the flagellum acquires other receptors, including
for androgen [309–312,351] and motility regulation is triggered by
fibroblast growth factor receptors [313,314].
With old age, the population of altered or aneuploid gametes does
not appear different than in young or adult people
[152,296,302,303,315]. Many altered chromosomal distribution (an-
euploidy), such as in testicle's raised temperature [316] or loss of E2
influence [317] can induce apoptotic death, as seen in man [294–297]
or rodents [298–300]. Then, the discharged gametes move or are
moved (due to subepithelial, lamina propria musculature) into toward
the rete testis toward the epididymis, their ultimate maturity storage
where some final maturation occurs, including some cytoplasmic ex-
cisions of some, few spermatozoa. There are still large percentage of
them with aneuploidy and diverse morphology and anomalies that are
unfunctional after ejaculation.
Even though these studies, questions unanswered ‘about the ‘con-
flicting findings expression pattern of ERα, ERβ and androgens’ in
sperm cells, especially that mitochondria can bear steroid receptors or,
at least, sensitive to E2 metabolites, that could modify the changing
oxidative metabolism pattern within the germ cell's differentiation. This
topic needs further clarifications even though some aspects of degen-
erative structures were found in human defects [37,151,286,315–318].
7.5.1. Lubarsch deposits, so-called crystals, as spermatogonia markers
Observed with light microscopy by Lubarsch [319,320] and re-
ported in Ref. [278]; then, reviewed with ultrastructure aspects, these
‘markers’ seemed to be usually recognized as filamentous components
aggregated as elongated deposits in spermatogonia
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[147–150,152,284,291,315,321,322]. To find out more about these
‘markers, whether transient macromolecular smudge or structure and
about their nature, specific molecular evidences should investigate the
topic.
8. Analgesic and contraceptive activities
Some pharmaceutical compounds can influence male fertility [323],
and an analgesic such as Ibuprofen have been associated with inducing
hypogonadism [324–326]. Use of ibuprofen during fetal life has been
shown to suppress transcriptional activity of androgen synthesis within
the testes. This loss of function has resulted in testicular atrophy
[324–326]. This once again illustrates on one hand, the role androgens,
associated with E2, that play in preventing testicular atrophy and on
the other hand, some possibility of implications for male contraception
before ageing, progressive sort of ‘andropause’ [327]. Other nutritional
additives or frequent fungicides need to be evaluated about public
health as they are commonly used and perturb the reproductive system
[328,329].
9. The myoid cells and interstitium
These peculiar smooth muscles of the interstitium testis, located
along the basal laminae of the seminiferous tubule, mentioned above
[148–152,206–210,330] were generated by the mesenchyme testis
[330,331]. Myoid cells have been shown to bear ERs-A. Interactions
between these smooth muscle cells, among the stroma, with Sertoli cells
and other connective tissue cells through paracrine and intracrine in-
teractions in rodents [332–334] and other animals (horses) where re-
productive and commercial interests have predominated more than
scientific value [335]. This detection of E2 receptor type A likely could
stimulate interests in the future for being influenced by environmental
poisons along with ageing and, thus for indirectly influencing sper-
miogenesis as perturbations of E2 can contribute to clinical conditions
evoked above.
Moreover, if many ancient studies have reported intratesticular
nerves and suspected to exert some regulatory effects on the functions
of the male gonad, including the seminiferous epithelium and inter-
stitium cell's and tissue's functions. However, quasi all of them included
development and are limited to young adult. Close association of tes-
ticular nerve fibers with myoid cells of the seminiferous tubules has
been shown in rats and humans [331,337–340]. Direct effects of nor-
adrenaline and acetylcholine on the contractility of seminiferous tu-
bules have also been evidenced in vitro [337,338] and testicular nerves
close to tubules are, therefore, thought to be involved in contraction of
seminiferous tubules. In human testes of newborns, adults and the aged
are innervated by NPY fibers, which are located in the interstitial
compartments and around blood vessels [341–346]. Thus, no adre-
nergic nerves were detected [346] but peptidergic nerves and im-
munoreactive to PGP 9.5, NPY and CPON were found running along the
tubules. It is possible that neuropeptides, such as NPY and calcitonin
gene-related peptide (CGRP), regulate motility similarly to other
structures made of non-vascular smooth musculature motion
[347,348]. Furthermore, an evident expression of NPY and CPON in the
peritubular myoid cells was for the first time detected in their study.
This data, obtained with light microscopy could bring question whether
the peptide's location should not be verified with fine structure, because
of ‘en-passant’ fine nerve endings could be there instead and the peptide
could co-localize with nerve endings of the myoid cells. The interesting
data could then be assumed these peptidergic nerves run along the
tubule walls could be implicated in contraction of seminiferous tubules
in the young adult human testis, devoid of monoaminergic nerves, and
could serve as major neuronal regulators for testicular functions at that
age. Also, other regulatory signals originated from blood vessels, such
as endothelins [349,350], and other signals to discover, to participate
in a paracrine control of spermatogenesis cannot yet be ruled out, but
no study has reported data for old males insofar
[148–150,206–210,330–342].
Up until today, literature searches mainly notice the understanding
of development and deals with diagrammatic autocrine-paracrine-en-
docrine models that could intervene with aging morphology or trans-
lational anatomical data [333,336,344]. The only indication of changes
are the ones one has pointed to an atrophy and ‘clearing’ of stroma
content in the seminiferous interstitium [330–333,336] and ex-
emplified in our illustrative figures.
Dealing with microscopic anatomy, one can recognize that the ar-
chitecture of the lamina propria depicts a continuous smooth muscle
layer with increased thickening from the myoid ‘upstream’ delicate
layer of the seminiferous tubules that progresses ‘downstream’ with the
rete testis, efferent ducts, epididymis and deferent ducts. This overall
anatomical and functional continuity where innervation and E2 level
could ‘impregnate’ this muscle tissue, regulate maintenance of inter-
cellular contacts (gap junctions) and, thus, indeed motility waves
during ejaculation, similarly as it is done in female with uterine mus-
culature and one of other peptides, such as oxytocine [348–352].
Interactive regulations between seminiferous tubule components
SCs with components of interstitial cells (i.e. LCS) and myoid ones,
involving maturation and aging have been proposed based on murine
models, including for human normal and some defects but yet to be
verified morphologically and with aging [350,353,354].
10. Clinical aspects and conditions
Declining fertility has been recorded in most industrialized coun-
tries, where delayed child bearing is common [355–360]. The pro-
gressive decline in man spermatogenesis and reproduction are known
with multiple causes in ageing, such as environmental [15–17] and
metabolism changes with decreased gonadotropin activities [360–363],
growth hormone [362], accumulated reactive oxygen species of life-
time, including adiposity and its adipokines [355,358,364–367]. In
some cases, malnutrition [364] and other maladies, such as mumps
orchitis accompanied with gynecomastia [367,368] would favor early
infertility. There, among pelvic changes [365], vascular defects and
varicoceles [367,368]. The decline or loss of physical activity, bearing
in mind that some fitness maintenance would assist aged man in his
basic health more than inactivity [369,370]. Finally, T supplements
have been used [371–374]; let us allow us to remark that if this would
call for another subject to write about, athletes and sports competitions
do not mix with extra T and other androgens intake as, most of the time
and in the long term, they can induce endocrine changes and other
serious pathologies including virilism, stroke, heart attack, prostate
tumorigenesis, liver and reproductive defects [371–375].
11. Concluding remarks
New tools and techniques have enabled tremendous progress in
molecular analysis of components that elucidate numerous critical as-
pects of estrogen signaling in the testis functions and maintenance.
Generation of transgenic animals has allowed analysis of the physio-
logical roles of the estrogen-signaling components in biologically re-
levant models to comprehend that testes have been known to be targets
for E2 and metabolites along with those clinical conditions that have
also allowed to highlight the farthest boundary on the E2 functional
aspects in male gender. Through the biomedical literature dealing with
the topic, testicular atrophy and/or dysfunction appears to follow E2
decline [317]; this change could probably follow not only a desensiti-
zation or depletion of expressed E2 receptors but a siphoning over-
activity of 5α-reductase away from declining aromatase [50,52] could
contribute to other defects in the elderly (i.e. prostate hypertrophy)
(Fig. 1). Additionally, some general [375] and local genital ischemia
[13,365,375] or faults in lymphatic drainage could also be partially
responsible for testicular atrophy (Fig. 4). Perhaps, more
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fundamentally, as the overall vascular-lymphatic supply fitness de-
clines, the poorly studied pineal relationships with hypothalamo-pi-
tuitary-testis axis cycles slow down and clearance of pituitary gona-
dotropins and other associated components
[7,50,169,360–363,375–377] could further influence on the testicle's
tissues hormone's and receptor's expressions, as well as some local in-
nervation and signals that are still to be studied [346,354]. All of these
factors and interactions could initiate some entropic cascade ahead of
testicular ischemia resulting in ageing testicular, reproductive atrophy
while sub-mucosal sclerosis installs. Most of the histology and ultra-
structural changes reported have demonstrated similar retrograde in-
volution to fit all with what was noted by Ref. [318] and emphasized by
Paniagua et al. [150,152] that ‘…there is no definite age at which
testicular involution begins, and the onset and severity of testicular
lesions are subjected to pronounced individual variations.’ A lesser
production of final spermatids follows incomplete differentiation and
atrophic changes ensue. Could we suggest that further translational
biomedical research studies focus on longitudinal studies on humans
ageing to solidify the cause(s) of testicular atrophy.
12. Common language with historical connections
Metaphoric word issued from Latin ‘testiculus’ (pl. testiculi), di-
minutive of ‘testis’ (translated: ‘witness’ out of old French ‘temoign’
(about 1150) combining ‘testimonium’ (proof) and ‘testis’ (a third
person of proof’ as of in the ancient Latin Plaute as in the sentence: ‘...
Ipse sum testis’; translated: ‘But I am witness’) [378]. Old English had
Celtic ‘beallucas’ (see the Middle English, ballockwort (circa 1300 as in
‘ballocks’) and ‘herþan’, probably originally “leather bag” (‘heorþa’ =
“deer-skin”). The commonest slang terms for them in other languages
are words that mean “balls,” “stones,” “nuts,” “eggs.” The slang of
“testicles” sense has tended to nudge the word toward taboo territory
[379]. Even though, about 75 years ago, December 22, 1944, during the
Second World-War Bastogne barricade, a courageous U.S. army com-
mander used it foully against a Nazi messenger requesting surrendering
of the Belgian city [380].
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